Growth Metrics

Opus Genetics (IRD) Share-based Compensation Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. Growth (3y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -34.72%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 4.80%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 10.78%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 2.55%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 20.65%
10 Opus Genetics 357.99 Mn 298.03 Mn - -81.90%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -81.90%
Dec 31, 2025 -27.13%
Sep 30, 2025 102.00%
Jun 30, 2025 26.27%
Mar 31, 2025 27.07%
Dec 31, 2024 87.59%
Jun 30, 2024 202.91%
Mar 31, 2024 -20.84%
Dec 31, 2023 11.49%
Sep 30, 2023 -2.38%
Jun 30, 2023 65.10%
Mar 31, 2023 1,493.88%
Dec 31, 2022 -158.26%
Sep 30, 2022 2.96%
Jun 30, 2022 51.63%
Mar 31, 2022 40.34%
Dec 31, 2021 37.19%
Sep 30, 2021 -54.80%
Jun 30, 2021 -52.30%
Mar 31, 2021 18.54%
Dec 31, 2020 26.38%
Sep 30, 2020 39.36%
Jun 30, 2020 3.13%
Mar 31, 2020 -39.42%
Dec 31, 2019 -27.12%
Sep 30, 2019 -37.38%
Jun 30, 2019 -28.63%
Mar 31, 2019 -22.28%
Dec 31, 2018 -42.26%
Sep 30, 2018 7.70%
Jun 30, 2018 -0.59%
Mar 31, 2018 74.05%
Dec 31, 2017 11.22%
Sep 30, 2017 11.73%
Jun 30, 2017 29.54%
Mar 31, 2017 28.81%
Dec 31, 2016 163.88%
Sep 30, 2016 76.04%
Jun 30, 2016 86.23%
Mar 31, 2016 -2.66%
Dec 31, 2015 220.39%
Sep 30, 2015 54.91%
Jun 30, 2015 74.99%
Mar 31, 2015 -14.87%
Dec 31, 2014 13.80%
Sep 30, 2014 4.97%
Jun 30, 2014 -8.00%
Mar 31, 2014 -14.03%
Dec 31, 2013 27.37%
Sep 30, 2013 -63.03%